Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease

Supplemental Data

• Supplemental Table S1 (.pdf, 433 KB) - Clinical and biochemical features of the control group included in the association analysis of the rs72613567 variant and NAFLD (fatty liver) as disease trait
• Supplemental Figure S1 (.jpg, 295 KB) - Representative plot of DNA Sanger sequencing of a patient carrying the rs72613567 (-/-) and a patient carrying the (A/A) genotype, upper (a) and lower (b) panel, respectively.
• Supplemental Methods (.pdf, 284 KB) - Biochemical determinations; genetic analysis (primer sequences).
• Supplemental Table S2 (.pdf, 293 KB) - The gene list for differentially expressed genes in the liver of patients carrying the rs72613567 (-/-) genotype relative to the expression levels of patients homozygous for the A-INS allele